Selective or Universal Newborn Screening for Hemoglobinopathies: Economics, Ethics, and Evidence

Presented by: Dr. Scott Grosse, PhD, Senior Health Economist
Centers for Disease Control and Prevention
U.S. Department of Health and Human Services National Center on Birth Defects and Developmental Disabilities 

Scott Grosse trained in population and development economics at the University of Michigan. After spending several years conducting training and providing technical assistance on economic-demographic modeling in developing countries, he switched to public health and received a doctorate in Population Planning and International Health in 1996. Since 1996 he has been employed at the Centers for Disease Control and Prevention (CDC) in Atlanta. He is the lead economist at CDC's National Center on Birth Defects and Developmental Disabilities. His work includes estimates of the costs associated with genetic or gene-environment disorder such as spina bifida, congenital hearing loss, and cystic fibrosis, as well as economic evaluation of genetic testing conducted as part of newborn screening.

The presentation will be moderated by: Dr. Wendy Ungar, Senior Scientist, CHES